Myriad Genetics, Inc. · NASDAQ:MYGN

Davis Mark Steven sold 6,100 Myriad Genetics, Inc. shares (Form 4)

Traded Nov 18, 2026 · Filed Nov 19, 2026

On Nov 18, 2026, Davis Mark Steven (Director) sold 6,100 Myriad Genetics, Inc. shares at US$5.62 for US$34,252, leaving 100,565 shares. Filed Nov 19, 2026 (Form 4).

Sold
6,100 shares
Price
US$5.62
Value
US$34,252
Holding after
100,565 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 18, 2026Common StockSale6,100US$5.62100,565Direct

Source

Download original · View original at SEC

Related